ALX Oncology
ALXO
#9346
Rank
A$0.20 B
Marketcap
A$1.60
Share price
3.92%
Change (1 day)
-27.67%
Change (1 year)

Earnings for ALX Oncology (ALXO)

Earnings in 2026 (TTM): -A$0.12 Billion

According to ALX Oncology's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.16 Billion, an increase over its 2024 earnings that were of -A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ALX Oncology from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.12 Billion-22.35%
2025 -A$0.16 Billion-24.81%
2024 -A$0.21 Billion-16.4%
2023 -A$0.25 Billion27.41%
2022 -A$0.19 Billion49.61%
2021 -A$0.13 Billion86.94%
2020 -A$67.52 Million132.9%
2019 -A$28.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 96.44%๐Ÿ‡บ๐Ÿ‡ธ USA